Israel biopharma cannabis research

Biotech Company Receives Israel Approval to Research on Cannabinoids

Everywhere we look it seems the terms CBD and CBG and THCDHSJAJDKSL are being thrown about everywhere.

With 483 known compounds i wonder which one will become the next big thing.

Patents on nature?

A common avenue pharmaceutical companies are looking at right now is how they can patent and produce cannabis-derived products. Which is not so easy considering some of the rules when it comes to putting a patent on something. You cannot patent a discovery or nature.

The cannabis plant, with its inherent chemical constituents, occurs naturally.

Israel biopharma cannabis research

So a person would not be able to patent the naturally occurring plant or the chemicals found naturally in the product. However, that person would be free to patent methods of extracting or using chemicals from the plant. Those methods of making synthetic versions of those chemicals or making other chemicals derived from those natural chemicals. And this is where we find ourselves today with many companies around the world scrambling to do just that.

Who are Can-Fite BioPharma?

Can-Fite BioPharma Ltd. is a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases.

Israel biopharma cannabis research

They have a technology platform that is designed to address multi-billion dollar markets in the treatment of cancer, liver, inflammatory disease and COVID-19.

They recently announced they have received approval from the Medical Cannabis Unit of Israel’s Ministry of Health to conduct pre-clinical studies on the effect of nanomolar concentrations of cannabinoid fractions on the proliferation and functionality of cancer, inflammatory, and adipocyte cells (fat cells).

Israel biopharma cannabis researchIsrael biopharma cannabis research

CEO Pnina Fishman stated

We are excited to embark on research to advance our cannabinoids program, which leverages our current IP platform, technology, and discovery lab assets to cost-and-time-efficiently generate findings in one of the fastest-growing and promising areas in the pharmaceutical space. As a world leader in A3AR, Can-Fite is ideally positioned to identify and develop cannabinoids at nanomolar concentrations to treat diseases effectively and safely“.

Israel biopharma cannabis research

Israel’s Cannabis Perspective

Israel was one of the pioneers of cannabis research. An early adopter of medical cannabis, and one of the few countries that has embraced of medical cannabis imports and exports. For example, Israel recently exported medical cannabis to Australia. Nevertheless, Israel still lags behind countries like Canada that have legalized cannabis for recreational purposes. But that’s changing. States the attorney Griffen Thorne. So maybe this year we could se legalization happening in Israel? We’ll see.

Israel biopharma cannabis research

About the author

Leave a Reply

Your email address will not be published. Required fields are marked *

Click to Hide Advanced Floating Content
en_US
×